← FDA Drug Approvals (Drugs@FDA)

EMPAGLIFLOZIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2022-08-03

Drug application

FDA Application #

ANDA212138

Application type

Abbreviated New Drug Application (Generic)

Brand name

EMPAGLIFLOZIN

Generic name

Empagliflozin

Active ingredients

EMPAGLIFLOZIN

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

ZYDUS PHARMS

First approval

2022-08-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown